,
your personalized virtual assistant to find clinical trials. Go head, 
Susana Campos, MD
Dana-Farber Cancer InstituteBoston, Massachusetts - 02115 |
- CLINICAL TRIALS 7
- CONDITIONS9
- INTERVENTIONS13
- SINCE2006
Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod
August 2008 - December 2011
AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies
February 2010 - February 2012
Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus
August 2006 - August 2010
Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian Fallopian Tube or Primary Peritoneal Cancer
September 2008 - December 2011
Sunitinib in Recurrent and Refractory Ovarian Fallopian Tube and Peritoneal Carcinoma
September 2008 - September 2011
Carboplatin and Pralatrexate in Patients With Recurrent Platinum-Sensitive Ovarian Fallopian or Primary Peritoneal Cancer
August 2010 - August 2013
Avastin in Patients With Epithelial Ovarian Primary Peritoneal Serous or Fallopian Tube Cancer
March 2009 - March 2011
Neoplasms
Ovarian Neoplasms
Carcinoma
Peritoneal Neoplasms
Fallopian Tube Neoplasms
Endometrial Neoplasms
Uterine Cervical Neoplasms
Uterine Neoplasms
Mixed Tumor, Mullerian
Carboplatin
Gm-Csf
Dendritic Cell/Tumor Fusion Vaccine
Imiquimod
Oxaliplatin
Temsirolimus
Gemcitabine
Sunitinib
Radiation
Cediranib
Bevacizumab (Avastin)
Tumor Collection
Pralatrexate
